Clinical effectiveness of the Kampo medicine kamishoyosan for adjunctive treatment of tardive dyskinesia in patients with schizophrenia: A 16-week open trial

Psychiatry and Clinical Neurosciences

Volumn 61, Issue 5, 2007, Pages 509-514

  Lee, Jung Goo ^a   Shin, Bae Sub ^b   Lee, Yu Cheol ^c   Park, Sung Woo ^b   Kim, Young Hoon ^b  

^a Dong Suh Mental Hospital   (South Korea)

^b Inje University   (South Korea)

^c Dongnae Hospital   (South Korea)

Author keywords

Brain derived neurotrophic factor; Kamishoyosan; Kampo medicine; Schizophrenia; Tardive dyskinesia

Indexed keywords

ANGELICA GIGAS EXTRACT; ATRACTYLODIS RHIZOMA ALBA EXTRACT; BRAIN DERIVED NEUROTROPHIC FACTOR; BUPLEURUM ROOT; CORTEX MOUTAN RADICIS EXTRACT; GARDENIA EXTRACT; GARDENIA FRUCTUS EXTRACT; GINGER EXTRACT; GLYCYRRHIZA EXTRACT; HERBACEOUS AGENT; HOELEN EXTRACT; KAMISHOYOSAN; KAMPO; MENTHAE HERBA EXTRACT; NEUROLEPTIC AGENT; PAEONIA RADIX; PLANT EXTRACT; UNCLASSIFIED DRUG;

ADJUVANT THERAPY; ADULT; ARTICLE; CLINICAL EFFECTIVENESS; CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE SEVERITY; DYSKINESIA; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; OPEN STUDY; PROTEIN BLOOD LEVEL; REDUCTION; SCHIZOPHRENIA; TARDIVE DYSKINESIA; TREATMENT DURATION;

ADULT; ANTIPSYCHOTIC AGENTS; BRAIN-DERIVED NEUROTROPHIC FACTOR; COMPLEMENTARY THERAPIES; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUGS, CHINESE HERBAL; DYSKINESIA, DRUG-INDUCED; FEMALE; FOLLOW-UP STUDIES; HUMANS; KOREA; MALE; MEDICINE, KAMPO; MIDDLE AGED; NEUROLOGIC EXAMINATION; PHYTOTHERAPY; SCHIZOPHRENIA; TREATMENT OUTCOME;

EID: 34548691875     PISSN: 13231316     EISSN: 14401819     Source Type: Journal    
DOI: 10.1111/j.1440-1819.2007.01700.x     Document Type: Article

References (25)

1. Lohr JB, Kuczenski R, Niculescu AB. Oxidative mechanism and tardive dyskinesia. CNS Drugs 2003 17 : 47 62.
2. Jenner P, Marsden CD. Is the dopamine hypothesis of tardive dyskinesia completely wrong? Trends Neurosci. 1986 9 : 259 260.
3. Meshul CK, Casey DE. Regional, reversible ultrastructural changes in rat brain with chronic neuroleptic treatment. Brain Res. 1989 489 : 338 346.
4. Cadet JL, Lohr JB. Possible involvement of free radicals in neuroleptic-induced movement disorder. Evidence from treatment of tardive dyskinesia with vitamin E. Ann. N.Y. Acad. Sci. 1989 570 : 176 185.
5. Lohr JB. Oxygen radicals and neuropsychiatric illness. Some speculations. Arch. Gen. Psychiatry 1991 48 : 1097 1106.
6. Lohr JB, Browning JA. Free radical involvement in neuropsychiatric illnesses. Psychopharmacol. Bull. 1995 31 : 159 165.
7. Thoenen H. Neurotrophins and neuronal plasticity. Science 1995 270 : 593 598.
8. Lewin GR, Barde YA. Physiology of the neurotrophins. Annu. Rev. Neurosci. 1996 19 : 289 317.
9. Tan YL, Zhou DF, Zhang XY. Decreased plasma brain-derived neurotrophic factor levels in schizophrenic patients with tardive dyskinesia: Association with dyskinetic movements. Schizophr. Res. 2005 74 : 263 270.
10. Ishikawa T, Funahashi T, Kudo J. Effectiveness of the Kampo kamishoyosan (TJ-24) for tremor of antipsychotic-induced parkinsonism. Psychiatry Clin. Neurosci. 2000 54 : 579 582.
11. Yamada K, Kanba S. Herbal medicine (Kamishoyosan) in the treatment of premenstrual dysphoric disorder. J. Clin. Psychopharmacol. 2002 22 : 442.
12. Mantani N, Hisanaga A, Korure T, Kita T, Shimada Y, Terasawa K. Four cases of panic disorder successfully treated with Kampo (Japanese herbal) medicines: Kamishoyosan and Hange-koboku-to. Psychiatry Clin. Neurosci. 2002 56 : 617 620.
13. Mizowaki M, Toriizuka K, Hanawa T. Anxiolytic effect of Kami-Shoyo-San (TJ-24) in mice: Possible mediation of neurosteroid synthesis. Life Sci. 2001 69 : 2167 2177.
14. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th edn. American Psychiatric Association, Washington, DC, 1994.
15. Guy W. ECDEU Assessment Manual for Psychopharmacology, revised edn. US Department of Health, Education, and Welfare, Washington, DC, 1976.
16. Schooler NR, Kane JM. Research diagnoses for tardive dyskinesia. Arch. Gen. Psychiatry 1982 39 : 486 487.
17. Lohr JB, Cadet JL, Lohr MA, Jeste DV, Wyatt RJ. Alpha-tocopherol in tardive dyskinesia. Lancet 1987 1 : 913 914.
18. Adler LA, Rotrosen J, Edson R et al. Vitamin E treatment for tardive dyskinesia. Veterans Affairs Cooperative Study 394 Study Group. Arch. Gen. Psychiatry 1999 56 : 836 841.
19. Zhang XY, Zhou DF, Cao LY, Xu CQ, Chen DC, Wu GY. The effect of vitamin E treatment on tardive dyskinesia and blood superoxide dismutase: A double-blind placebo-controlled trial. J. Clin. Psychopharmacol. 2004 24 : 83 86.
20. Lohr JB, Kuczenski R, Niculescu AB. Oxidative mechanisms and tardive dyskinesia. CNS Drugs 2003 17 : 47 62.
21. Yokozawa T, Liu ZW, Chen CP. Protective effects of Glycyrrhizae radix extract and its compounds in a renal hypoxia (ischemia)-reoxygenation (reperfusion) model. Phytomedicine 2000 6 : 439 445.
22. Eum HA, Lee WY, Kim SH et al. Anti-inflammatory activity of CML-1: An herbal formulation. Am. J. Chin. Med. 2005 33 : 29 40.
23. Watanabe H, Kobayashi T, Tomii M et al. Effects of Kampo herbal medicine on plasma melatonin concentration in patients. Am. J. Chin. Med. 2002 30 : 65 71.
24. Kim HJ, Chang EJ, Cho SH, Chung SK, Park HD, Choi SW. Antioxidative activity of resveratrol and its derivatives isolated from seeds of Paeonia lactiflora. Biosci. Biotechnol. Biochem. 2002 66 : 1990 1993.
25. Dorman HJ, Kosar M, Kahlos K, Holm Y, Hiltunen R. Antioxidant properties and composition of aqueous extracts from Mentha species, hybrids, varieties, and cultivars. J. Agric. Food Chem. 2003 51 : 4563 4569.